SLN: Silence Therapeutics Plc Financial Statements
Balance sheet, income statement, and cash flow statements for Silence Therapeutics Plc (SLN).
$324.83M Market Cap.
SLN Market Cap. (MRY)
SLN Shares Outstanding (MRY)
SLN Assets (MRY)
Total Assets
$202.63M
Total Liabilities
$68.61M
Total Investments
$26.00M
SLN Income (MRY)
Revenue
$43.26M
Net Income
-$45.31M
Operating Expense
$94.77M
SLN Cash Flow (MRY)
CF Operations
-$67.64M
CF Investing
-$21.97M
CF Financing
$142.09M
SLN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $202,635,000 (69.64%) | $119,448,000 (-11.11%) | $134,375,000 (11.75%) | $120,242,500 (11.89%) |
Assets Current | $187,366,000 (81.64%) | $103,151,000 (-14.65%) | $120,857,500 (11.99%) | $107,916,250 (13.00%) |
Assets Non-Current | $15,269,000 (-6.31%) | $16,297,000 (20.56%) | $13,517,500 (9.66%) | $12,326,250 (3.02%) |
Goodwill & Intangible Assets | $9,704,000 (-6.18%) | $10,343,000 (-0.66%) | $10,411,250 (9.36%) | $9,520,000 (-6.46%) |
Shareholders Equity | -$134,023,000 (-509.39%) | -$21,993,000 (-179.71%) | $27,590,000 (158.88%) | $10,657,500 (-5.88%) |
Property Plant & Equipment Net | $1,975,000 (-14.43%) | $2,308,000 (-16.11%) | $2,751,250 (13.22%) | $2,430,000 (72.49%) |
Cash & Equivalents | $121,330,000 (76.38%) | $68,789,000 (0.39%) | $68,520,000 (-25.46%) | $91,921,250 (167.90%) |
Accumulated Other Comprehensive Income | $11,781,000 (9.85%) | $10,725,000 (311.51%) | $2,606,250 (35.30%) | $1,926,250 (-30.52%) |
Deferred Revenue | $52,096,000 (-36.13%) | $81,572,000 (-9.80%) | $90,436,250 (-5.73%) | $95,935,000 (12.24%) |
Total Investments | $26,004,000 (0%) | $0 (0%) | $20,765,000 (5418.94%) | $376,250 (-97.08%) |
Investments Current | $26,004,000 (0%) | $0 (0%) | $20,410,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $355,000 (-5.65%) | $376,250 (-0.66%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $972,000 (235.17%) | $290,000 (-74.64%) | $1,143,750 (176.44%) | $413,750 (-98.87%) |
Trade & Non-Trade Payables | $16,399,000 (5.55%) | $15,537,000 (-1.61%) | $15,791,250 (17.16%) | $13,478,750 (31.63%) |
Accumulated Retained Earnings (Deficit) | $474,044,000 (9.76%) | $431,894,000 (231.24%) | -$329,078,750 (-18.07%) | -$278,707,500 (-21.04%) |
Tax Assets | $0 (0%) | $0 (0%) | $18,602,500 (114.28%) | $8,681,250 (96.41%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $117,000 (-66.18%) | $346,000 (-37.94%) | $557,500 (225.55%) | $171,250 (-59.82%) |
Debt Current | $117,000 (-48.68%) | $228,000 (-59.10%) | $557,500 (225.55%) | $171,250 (-59.82%) |
Debt Non-Current | $0 (0%) | $118,000 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $68,612,000 (-29.60%) | $97,455,000 (-8.74%) | $106,785,000 (-2.56%) | $109,585,000 (13.98%) |
Liabilities Current | $16,822,000 (-24.69%) | $22,336,000 (-18.57%) | $27,428,750 (44.68%) | $18,958,750 (-40.70%) |
Liabilities Non-Current | $51,790,000 (-31.06%) | $75,119,000 (-5.34%) | $79,356,250 (-12.44%) | $90,626,250 (41.23%) |
SLN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $43,258,000 (36.71%) | $31,643,000 (46.12%) | $21,655,000 (39.54%) | $15,518,750 (126.59%) |
Cost of Revenue | $11,810,000 (-8.21%) | $12,867,000 (-4.43%) | $13,463,000 (44.45%) | $9,320,000 (98.19%) |
Selling General & Administrative Expense | $26,884,000 (2.52%) | $26,222,000 (2.10%) | $25,682,000 (2.69%) | $25,010,000 (43.09%) |
Research & Development Expense | $67,883,000 (19.22%) | $56,937,000 (30.74%) | $43,550,000 (13.25%) | $38,456,250 (52.23%) |
Operating Expenses | $94,767,000 (13.96%) | $83,159,000 (20.12%) | $69,232,000 (9.08%) | $63,466,250 (35.16%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $65,000 (-83.90%) |
Income Tax Expense | $845,000 (-11.61%) | $956,000 (38.95%) | $688,000 (108.54%) | -$8,057,500 (-84.49%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$45,309,000 (16.45%) | -$54,228,000 (-7.74%) | -$50,334,000 (-2.18%) | -$49,262,500 (-21.09%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$45,309,000 (16.45%) | -$54,228,000 (-7.74%) | -$50,334,000 (-2.18%) | -$49,262,500 (-21.09%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$45,309,000 (16.45%) | -$54,228,000 (-7.74%) | -$50,334,000 (-2.18%) | -$49,262,500 (-21.09%) |
Weighted Average Shares | $138,752,224 (24.69%) | $111,277,250 (15.21%) | $96,584,512 (7.58%) | $89,777,000 (14.55%) |
Weighted Average Shares Diluted | $138,752,224 (24.69%) | $111,277,250 (15.21%) | $96,584,512 | - |
Earning Before Interest & Taxes (EBIT) | -$44,464,000 (16.53%) | -$53,272,000 (-7.30%) | -$49,646,000 (13.29%) | -$57,255,000 (-28.24%) |
Gross Profit | $31,448,000 (67.49%) | $18,776,000 (129.20%) | $8,192,000 (32.16%) | $6,198,750 (188.82%) |
Operating Income | -$63,319,000 (1.65%) | -$64,383,000 (-5.48%) | -$61,040,000 (-6.59%) | -$57,267,500 (-27.80%) |
SLN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$21,966,000 (-213.85%) | $19,294,000 (194.13%) | -$20,498,000 (-289.01%) | $10,845,000 (-9.79%) |
Net Cash Flow from Financing | $142,087,000 (344.90%) | $31,937,000 (-39.26%) | $52,581,000 (36.97%) | $38,388,750 (99.06%) |
Net Cash Flow from Operations | -$67,640,000 (-36.75%) | -$49,462,000 (13.29%) | -$57,044,000 (-770.51%) | $8,507,500 (163.16%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $52,481,000 (2866.70%) | $1,769,000 (107.09%) | -$24,961,000 (-143.23%) | $57,741,250 (223.71%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$21,755,000 (-212.43%) | $19,350,000 (196.98%) | -$19,953,000 (-259.62%) | $12,500,000 (0.00%) |
Capital Expenditure | -$211,000 (-276.79%) | -$56,000 (67.63%) | -$173,000 (89.44%) | -$1,638,750 (-158.07%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | -$263,750 (47.51%) |
Issuance (Purchase) of Equity Shares | $142,087,000 (344.90%) | $31,937,000 (-39.26%) | $52,581,000 (36.04%) | $38,652,500 (95.34%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $60,000 (-91.99%) | $749,000 (109.23%) | -$8,119,000 (-6085.90%) | -$131,250 (68.75%) |
Share Based Compensation | $16,307,000 (0.20%) | $16,274,000 (28.28%) | $12,686,000 (17.57%) | $10,790,000 (96.41%) |
Depreciation Amortization & Accretion | $593,000 (-4.51%) | $621,000 (4.19%) | $596,000 (16.01%) | $513,750 (-13.66%) |
SLN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 72.70% (22.60%) | 59.30% (56.88%) | 37.80% (-5.26%) | 39.90% (27.48%) |
Profit Margin | -104.70% (38.91%) | -171.40% (26.25%) | -232.40% (26.78%) | -317.40% (46.57%) |
EBITDA Margin | -101.40% (39.06%) | -166.40% (26.53%) | -226.50% (38.05%) | -365.60% (43.16%) |
Return on Average Equity (ROAE) | -64.80% (88.33%) | -555.30% (-91.15%) | -290.50% (35.19%) | -448.20% (-106.35%) |
Return on Average Assets (ROAA) | -20.30% (55.48%) | -45.60% (-13.72%) | -40.10% (7.39%) | -43.30% (12.17%) |
Return on Sales (ROS) | -102.80% (38.95%) | -168.40% (26.56%) | -229.30% (37.84%) | -368.90% (43.41%) |
Return on Invested Capital (ROIC) | -59.40% (70.15%) | -199.00% (59.70%) | -493.80% (-35.62%) | -364.10% (-106.99%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -6.95 (41.19%) | -11.82 (-20.87%) | -9.78 | - |
Price to Sales Ratio (P/S) | 7.36 (-63.87%) | 20.36 (-10.19%) | 22.67 (-50.79%) | 46.07 (-45.10%) |
Price to Book Ratio (P/B) | -2.42 (92.06%) | -30.54 (-253.94%) | 19.84 (-70.43%) | 67.08 (32.17%) |
Debt to Equity Ratio (D/E) | -0.51 (88.45%) | -4.43 (-214.50%) | 3.87 (-62.36%) | 10.28 (21.11%) |
Earnings Per Share (EPS) | -0.99 (32.65%) | -1.47 (5.77%) | -1.56 | - |
Sales Per Share (SPS) | 0.94 (9.61%) | 0.85 (26.75%) | 0.67 (29.67%) | 0.52 (98.09%) |
Free Cash Flow Per Share (FCFPS) | -1.47 (-9.89%) | -1.33 (24.87%) | -1.78 (-872.61%) | 0.23 (142.59%) |
Book Value Per Share (BVPS) | -2.9 (-388.70%) | -0.59 (-169.19%) | 0.86 (140.73%) | 0.36 (-17.78%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.17 (41.82%) | 2.94 (-23.61%) | 3.85 (4.05%) | 3.7 (-0.64%) |
Enterprise Value Over EBIT (EV/EBIT) | -6 (45.45%) | -11 (-22.22%) | -9 (18.18%) | -11 (15.38%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -5.64 (50.37%) | -11.37 (-28.06%) | -8.88 (19.50%) | -11.03 (13.53%) |
Asset Turnover | 0.19 (-27.07%) | 0.27 (54.65%) | 0.17 (26.47%) | 0.14 (63.86%) |
Current Ratio | 11.14 (141.19%) | 4.62 (4.81%) | 4.41 (-22.59%) | 5.69 (90.56%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$67,851,000 (-37.02%) | -$49,518,000 (13.46%) | -$57,217,000 (-933.00%) | $6,868,750 (148.70%) |
Enterprise Value (EV) | $247,567,277 (-58.64%) | $598,568,706 (37.45%) | $435,470,421 (-30.41%) | $625,744,527 (11.38%) |
Earnings Before Tax (EBT) | -$44,464,000 (16.53%) | -$53,272,000 (-7.30%) | -$49,646,000 (13.39%) | -$57,320,000 (-27.23%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$43,871,000 (16.68%) | -$52,651,000 (-7.34%) | -$49,050,000 (13.55%) | -$56,741,250 (-28.80%) |
Invested Capital | $54,896,000 (199.55%) | $18,326,000 (-35.86%) | $28,572,500 (207700.00%) | $13,750 (-99.96%) |
Working Capital | $170,544,000 (111.03%) | $80,815,000 (-13.50%) | $93,428,750 (5.03%) | $88,957,500 (40.02%) |
Tangible Asset Value | $192,931,000 (76.83%) | $109,105,000 (-11.99%) | $123,963,750 (11.96%) | $110,722,500 (13.81%) |
Market Capitalization | $324,834,777 (-51.64%) | $671,689,956 (22.71%) | $547,367,921 (-23.44%) | $714,917,027 (24.40%) |
Average Equity | $69,908,000 (615.87%) | $9,765,500 (-43.65%) | $17,329,062 (57.67%) | $10,990,625 (-41.32%) |
Average Assets | $223,283,125 (87.76%) | $118,921,375 (-5.27%) | $125,539,062 (10.26%) | $113,853,125 (37.95%) |
Invested Capital Average | $74,894,312 (179.81%) | $26,766,188 (166.21%) | $10,054,375 (-36.05%) | $15,723,125 (-38.06%) |
Shares | 141,644,488 (22.10%) | 116,009,788 (7.74%) | 107,680,012 (19.94%) | 89,777,000 (14.55%) |